AnalystsThomas ShraderThomas Shrader's Stock Forecasts
AnalystsThomas Shrader
Analyst Ranking
Bottom 15%
#4715 out of 5510 analysts
Average Return
-0.25%
Win Rate
38%48 out of 127
Risk vs Reward
Poor
Good
Thomas Shrader's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Ovid Therapeutics IncOVID | +474.32% | $0.44 | $2.55 | 2025-03-24 - 2026-03-23 | Strong Buy |
Opus Genetics IncIRD | +167.26% | $2.26 | $6.04 | 2026-01-20 - 2026-09-11 | Strong Buy |
Annexon IncANNX | +136.19% | $2.10 | $4.96 | 2023-05-25 - 2024-05-24 | Strong Buy |
Alto Neuroscience IncANRO | +131.88% | $13.80 | $32.00 | 2025-11-17 - 2026-09-11 | Strong Buy |
Compass Pathways PLCCMPS | +128.14% | $6.29 | $14.35 | 2025-10-13 - 2026-09-11 | Strong Buy |
Thomas Shrader Analyst Color
Get additional color on Thomas Shrader's coverage of popular stocks
Thomas Shrader's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Serina Therapeutics IncSER | 2 | Strong Buy | $8.00 | +260.36% | Reiterates | 4 days ago |
Opus Genetics IncIRD | 6 | Strong Buy | $12.00 | +98.68% | Reiterates | 5 days ago |
Bioage Labs IncBIOA | 4 | Strong Buy | $40.00 | +371.14% | Reiterates | 6 days ago |
Neonc Technologies Holdings IncNTHI | 3 | Strong Buy | $15.00 | +307.61% | Reiterates | 6 days ago |
Tiziana Life Sciences LtdTLSA | 1 | Strong Buy | $7.00 | +629.17% | Initiates Coverage On | 11 days ago |
Ac Immune SaACIU | 7 | Strong Buy | $8.00 | +189.86% | Reiterates | 25 days ago |
Nrx Pharmaceuticals IncNRXP | 6 | Strong Buy | $10.00 | +194.12% | Reiterates | a month ago |
Bright Minds Biosciences IncDRUG | 6 | Strong Buy | $147.00 | N/A | Reiterates | a month ago |
Alto Neuroscience IncANRO | 3 | Strong Buy | $37.00 | +15.63% | Maintains | a month ago |
Harrow IncHROW | 8 | Strong Buy | $63.00 | +82.71% | Reiterates | a month ago |
Gain Therapeutics IncGANX | 6 | Strong Buy | $5.00 | +185.71% | Reiterates | a month ago |
Compass Pathways PLCCMPS | 4 | Strong Buy | $25.00 | +74.22% | Maintains | 2 months ago |
Invivyd IncIVVD | 7 | Strong Buy | $10.00 | +1,173.89% | Reiterates | 2 months ago |
Novavax IncNVAX | 2 | Strong Buy | $19.00 | +101.70% | Reiterates | 3 months ago |
Denali Therapeutics IncDNLI | 6 | Strong Buy | $39.00 | +84.92% | Reiterates | 4 months ago |
Stoke Therapeutics IncSTOK | 4 | Strong Buy | $39.00 | +34.34% | Reiterates | 4 months ago |
Acumen Pharmaceuticals IncABOS | 5 | Strong Buy | $8.00 | +173.97% | Reiterates | 6 months ago |
Ovid Therapeutics IncOVID | 4 | Strong Buy | $4.00 | +48.70% | Reiterates | 6 months ago |
Alector IncALEC | 5 | Strong Buy | $6.00 | +180.37% | Upgrades | 6 months ago |
Vaxcyte IncPCVX | 8 | Strong Buy | $89.00 | +49.66% | Maintains | 7 months ago |
Biohaven LtdBHVN | 4 | Strong Buy | $16.00 | +25.89% | Reiterates | 10 months ago |
Coya Therapeutics IncCOYA | 3 | Strong Buy | $16.00 | +265.30% | Maintains | 10 months ago |
Aldeyra Therapeutics IncALDX | 2 | Strong Buy | $9.00 | +571.64% | Reiterates | 10 months ago |
Arcturus Therapeutics Holdings IncARCT | 2 | Strong Buy | $23.00 | +56.14% | Maintains | a year ago |
Verona Pharma PLCVRNA | 4 | Hold | N/A | N/A | Downgrades | a year ago |
Inmune Bio IncINMB | 3 | Hold | N/A | N/A | Downgrades | a year ago |
Promis Neurosciences IncPMN | 1 | Strong Buy | $200.00 | N/A | Initiates Coverage On | 3 years ago |
Precision Biosciences IncDTIL | 1 | Strong Buy | $60.00 | N/A | Maintains | 3 years ago |
Sigilon Therapeutics IncSGTX | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Annexon IncANNX | 2 | Strong Buy | $7.00 | N/A | Maintains | 3 years ago |
Leonabio IncLONA | 2 | Strong Buy | $100.00 | N/A | Maintains | 3 years ago |
Bioatla IncBCAB | 3 | Strong Buy | $650.00 | N/A | Maintains | 3 years ago |
Sqz Biotechnologies CoSQZB | 2 | Strong Buy | $15.00 | N/A | Maintains | 4 years ago |
Pliant Therapeutics IncPLRX | 1 | Strong Buy | $51.00 | N/A | Initiates Coverage On | 5 years ago |
Celularity IncCELU | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 5 years ago |
Oncosec Medical IncONCSQ | 1 | Strong Buy | $220.00 | N/A | Initiates Coverage On | 6 years ago |
Nuvation Bio IncNUVB | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 6 years ago |
Voyager Therapeutics IncVYGR | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Eidos Therapeutics IncEIDX | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Vaccinex IncVCNX | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
89bio IncETNB | 1 | Strong Buy | $58.00 | N/A | Maintains | 6 years ago |
Checkmate Pharmaceuticals IncCMPI | 1 | Strong Buy | $29.00 | N/A | Initiates Coverage On | 6 years ago |
Geron CorpGERN | 1 | Strong Buy | $3.00 | N/A | Maintains | 6 years ago |
Acorda Therapeutics IncACORQ | 1 | Hold | $840.00 | N/A | Maintains | 7 years ago |
Biogen IncBIIB | 3 | Hold | $346.00 | N/A | Downgrades | 8 years ago |
Momenta Pharmaceuticals IncMNTA | 2 | Strong Buy | N/A | N/A | Upgrades | 9 years ago |
Windtree Therapeutics IncWINT | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Kite Pharma IncKITE | 1 | Hold | N/A | N/A | Downgrades | 10 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.